Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

ALK-Abello

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of ALK-Abello's 2013 sales performance.

Positive mid-stage trial gives Allergy’s investors some welcome relief

Positive mid-stage trial gives Allergy’s investors some welcome relief

There are already immunotherapies on the market for grass pollen allergy - including for example Alk Abello/Merck &Co’s oral Grazax/Grastek product - but these can take months of treatment to

ALK-Abello appoints Søren Jelert as CFO

ALK-Abello appoints Søren Jelert as CFO He will be based at the company’s headquarters in Denmark. Dansih allergy immunotherapy company ALK-Abello has appointed Søren Jelert as its new chief financial officer, a role that sees ... ALK.”. Jelert will be based at ALK’s headquarters in

Cello Health Consulting expands its UK team

Cello Health Consulting expands its UK team Tarplee has over 30 years of life science industry experience and previously worked for the likes of Adherium, ALK Abello, Sanofi and Abbott.

Deal Watch July 2016

Deal Watch July 2016 And Finally, Reality Bites. ALK-Abello has issued a press release announcing that Merck &Co has walked away from the deal agreed in 2007 (with Schering-Plough) for the allergy treatments ... No sales figures have been released by either side, but

ALK Abelló's John Tarplee joins Adherium

ALK Abelló's John Tarplee joins Adherium UK. He brings over 30 years of sales and market expansion expertise, most recently in the role of senior vice president at Danish immunotherapy company ALK Abelló where he oversaw its

1 2 3 4 5 6 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
BASTARD . LONDON

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics